Editorial Review

Kidney International (1990) 37, 663–676; doi:10.1038/ki.1990.32

Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations

Richard J Johnson and William G Couser

Seattle, Washington, USA

Correspondence: Richard J Johnson MD, Division of Nephrology, Mail Stop RM-11, University of Washington, Seattle, Washington 98195, USA.

Received 5 June 1989; Revised 18 August 1989; Accepted 21 August 1989.

Top

References

  1. Blumberg BS, Alter HJ, Visnich S: A "new" antigen in Leukemia Sera. JAMA 191:541–546, 1965 | PubMed | ChemPort |
  2. Sherlock S: The natural history of hepatitis B. Postgrad Med J 63:7–11, 1987
  3. Maupas P, Melnick JL: Hepatitis B infection and primary liver cancer. Prog Med Virol 27:1–5, 1981 | PubMed | ChemPort |
  4. Onion DK, Crumpacker CS, Gilliland BC: Arthritis of hepatitis associated with Australia antigen. Ann Intern Med 75:29–33, 1971
  5. Alpert E, Isselbacher KJ, Schur PH: The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med 285:185–189, 1971
  6. Gocke DJ, Morgan C, Lockshin M, Hsu H, Bombardieri S, Christian CL: Association between polyarteritis and Australia antigen. Lancet 2:1149–1153, 1970
  7. Combes B, Shorey J, Barrera A, et al: Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 2:234–237, 1971 | PubMed | ISI | ChemPort |
  8. Myers BD, Griffel B, Naveh D, Jankielowitz T, Klajman A: Membranoproliferative glomerulonephritis associated with persistent viral hepatitis. Am J Clin Pathol 59:222–228, 1973
  9. Tiollais P, Pourcel C, Dejean A: The hepatitis B virus. Nature 317:489–495, 1985 | Article | PubMed | ISI | ChemPort |
  10. McCollum RW, Zuckerman AJ (preparers): Viral hepatitis: Report on a WHO informal consultation. J Med Virol 8:1–29, 1981
  11. Chairez R, Hollinger FB, Brunschwig JP, Dreesman GR: Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw. J Virol 15:182–190, 1975 | PubMed | ISI | ChemPort |
  12. Fields HA, Hollinger FB, Desmyter J, Melnick JL, Dreesman GR: Biochemical and biophysical properties of hepatitis B core particles derived from Dane particles and infected hepatocytes. Intervirol 8:336–350, 1977
  13. Yamada EI, Ishida N, Ohori H: Comparison of the antigenicity and protein composition of hepatitis B virus e antigen subtypes HBeAg/1 and HBeAg/2. J Gen Virol 4:895–903, 1983
  14. Pfaff E, Salfeld J, Gmelin K, Schaller H, Theilmann L: Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X-antibodies in human sera. Virology 158:456–460, 1987
  15. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH: Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 52:396–402, 1984 | PubMed | ISI | ChemPort |
  16. Robinson WS: The genome of hepatitis B virus. Ann Rev Microbiol 31:357–377, 1977
  17. Takahashi K, Akahane Y, Gotanda T, et al: Demonstration of hepatitis B e antigen in the core of Dane particles. J Immunol 122:275–279, 1979
  18. Matsuda K, Ohori H: Immunochemical characteristics of hepatitis B e antigen subspecificities, HBeAg/1 and HBeAg/2. J Immunol 141:1709–1713, 1988
  19. Chang L-J, Dienstag J, Ganem D, Varmus H: Detection of antibodies against hepatitis B virus polymerase antigen in hepatitis B-virus infected patients. Hepatology 10:332–335, 1989
  20. Rizetto M, Crivelli O: Hepatitis delta virus disease, in Chronic Hepatitis, edited by Liaw Y-F, New York, Elsevier Science Publishers B.V. (Biomedical Division), 1986, pp. 19–26
  21. Gocke DJ: Extrahepatic manifestations of viral hepatitis. Am J Med Sci 270:49–52, 1975
  22. Duffy J, Lidsky MD, Sharp JT, et al: Polyarthritis, polyarteritis and hepatitis B. Medicine 55:19–37, 1976
  23. Dienstag JL, Rhodes AR, Bhan AK, Dvorak AM, Mihm MC Jr, Wands JR: Urticaria associated with acute viral hepatitis type B. Studies of pathogenesis. Ann Int Med 89:34–40, 1978
  24. Schumacher HR, Gall GP: Arthritis in acute hepatitis and chronic active hepatitis. Pathology of the synovial membrane with evidence for the presence of Australia antigen in synovial membranes. Am J Med 57:655–663, 1974
  25. Popp JW Jr, Harrist TJ, Dienstag JL, et al: Cutaneous vasculitis associated with acute and chronic hepatitis. Arch Int Med 141:623–629, 1981
  26. Kussmaul A, Maier R: Ueber eine hisher nicht beschriebene eigenthumliche arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellahmung einhergeht. Deutsche Arch Klin Med 1:484–518, 1986
  27. Paull R: Periarteritis nodosa (panarteritis nodosa) with report of four proven cases. Calif Med 67:309–314, 1947
  28. Trepo C, Thivolet J: Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang 19:410–411, 1970
  29. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL: Vasculitis in association with Australia antigen. J Exp Med 134:330s–335s, 1971 | PubMed | ChemPort |
  30. Sack M, Cassidy JT, Bole GG: Prognostic factors in polyarteritis. J Rheumatol 2:411–420, 1975
  31. Ewald EA, Griffin D, McCune WJ: Correlation of angiographic abnormalities with disease manifestations and disease severity in polyarteritis nodosa. J Rheumatol 14:952–956, 1987
  32. Cohen RD, Conn DT, Ilstrup DM: Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc 55:146–155, 1980
  33. Fauci AS, Katz P, Haynes BF, Wolff SM: Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 301:235–238, 1979
  34. Scott DGI, Bacon PA, Elliott PJ, Tribe CR, Wallington TB: Systemic vasculitis in a district general hospital 1972–1980: Clinical and laboratory features, classification and prognosis of 80 cases. Quart J Med 51:292–311, 1982
  35. Reeves A, Bresnihan B: Clinical features, treatment and outcome of polyarteritis nodosa. Israel J Med Sci 156:90–92, 1987
  36. Ronco P, Verroust P, Mignon F, et al: Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: A report of 43 patients with 51 renal biopsies. Quart J Med 52:212–223, 1983
  37. Trepo CG, Zuckerman AJ, Bird RC, Prince AM: The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Path 27:863–868, 1974
  38. Budmiger H, Turina J, Streuli R, Bollinger A: [Diagnosis and clinical course of periarteritis nodosa]. Schweiz Med Wochenschr 116:1634–1639, 1986
  39. Gupta R, Kohler PF: Identification of HBsAg determinants in immune complexes from hepatitis B virus-associated vasculitis. J Immunol 132:1223–1228, 1984
  40. Razzak IA, Bauer FW, Itzel W: Hepatitis-B-antigenemia with panarteritis, diffuse proliferative glomerulitis and malignant hypertension. Am J Gastroenterol 68:476–480, 1975
  41. Heathcote EJL, Dudley FJ, Sherlock S: The association of polyarteritis and Australia antigen. (abstract) Digestion 6:280–281, 1972
  42. Trepo C, Thivolet J, Lambert R: Four cases of periarteritis nodosa associated with persistent Australia antigen. Digestion 5:100–107, 1972
  43. Sergent JS, Lockshin MD, Christian CL, Gocke DJ: Vasculitis with hepatitis B antigenemia. Long term observations in nine patients. Medicine 55:1–17, 1976 | PubMed | ChemPort |
  44. Reznik VM, Mendoza SA, Self TW, Griswold WR: Hepatitis B-asspciated vasculitis in an infant. J Pediatr 98:252–254, 1981
  45. Baker AL, Kaplan MM, Benz WC, Sidel JS, Wolfe HJ: Polyarteritis associated with Australia antigen-positive hepatitis. Gastroenterol 62:105–110, 1972
  46. Naber AHJ, De Vlaam AM, Breed WPM: Chronic active hepatitis and periarteritis in a patient with co-occurrence of circulatory hepatitis Bs antigen and anti-HBs. Neth J Med 29:189–191, 1986
  47. Shiels MT, Taswell HF, Czaja AJ, Nelson C, Swenke P: Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastroenterol 93:675–680, 1987
  48. Michalak T: Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases. Am J Pathol 90:619–632, 1978
  49. Michalak T, Krawczynski K: Vascular lesions in hepatitis B virus infection, in Systemic Effects of HBsAg Immune Complexes, edited by Bartoli E, Chiandussi L, Sherlock S, Rome, Piccin Medical Books, 1981, pp. 40–49
  50. Gower RG, Sausker WF, Kohler PF, Thorne GE, McIntosh RM: Small vessel vasculitis caused by hepatitis B virus immune complexes. J Allergy Clin Immunol 62:222–228, 1978
  51. Gerber MA, Brodin A, Steinberg D, Vernace, Yang C-P, Paronetto F: Periarteritis nodosa, Australia antigen and lymphatic leukemia. N Engl J Med 286:14–17, 1972
  52. Adu D, Howie AJ, Scott DGI, Bacon PA, McGonigle RJS, Michael J: Polyarteritis and the kidney. Quart J Med 62:221–237, 1987
  53. Furlong TJ, Ibels LS, Eckstein RP: The clinical spectrum of necrotizing glomerulonephritis. Medicine 66:192–201, 1987
  54. Droz D, Noel LH, Leibowitch M, Barbanel C: Glomerulonephritis and necrotizing angiitis. Adv Nephrol 8:343–363, 1979
  55. D'Agati V, Chander P, Nash M, Mancilla-Jimenez R: Idiopathic microscopic polyarteritis nodosa: Ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis 7:95–110, 1986
  56. Stilmant MM, Bolton WK, Sturgill BC, Couser WG: Acute crescentic glomerulonephritis without immune deposits. Clinical laboratory and renal pathologic characteristics of sixteen patients. Kidney Int 15:184–195, 1979 | PubMed |
  57. Rich AR: The role of hypersensitivity in periarteritis nodosa as indicated by seven cases developing during serum sickness and sulfonamide therapy. Bull Johns Hopkins 71:123–140, 1942
  58. Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis: Clinical, pathologic, immunologic, and therapeutic considerations. Ann Int Med 89:660–676, 1978 | PubMed | ChemPort |
  59. Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM: A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med 311:1407–1413, 1984 | PubMed | ChemPort |
  60. Germuth FG Jr: A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type. J Exp Med 97:257–282, 1953 | Article | PubMed |
  61. Rich AR, Gregory JE: The experimental demonstration that periarteritis nodosa is a manifestation of hypersensitivity. Bull Johns Hopkins 72:65–88, 1943
  62. Germuth FG, Heptinstall RH: The development of arterial lesions following prolonged sensitization to bovine gamma globulin. Bull Johns Hopkins 100:58–70, 1957
  63. De La Pava S, Nigogosyan G, Pickren JW: Fatal glomerulonephritis after receiving horse anti-human cancer serum. Arch Int Med 109:391–399, 1962
  64. Morita M, Kitajima K, Yoshizawa H, et al: Glomerulonephritis associated with arteritis in marmosets infected with hepatitis A virus. Brit J Exp Pathol 62:103–113, 1981
  65. Wands JR, Mann E, Alpert E, Isselbacher KJ: The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. J Clin Invest 55:930–936, 1975
  66. Drueke T, Barbanel C, Jungers P, et al: Hepatitis B antigen-associated periarteritis nodosa in patients undergoing long-term hemodialysis. Am J Med 68:86–90, 1980
  67. Prince AM, Trepo C: Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. Lancet 1:1309–1312, 1971
  68. Fye KH, Becker MJ, Theofilopoulous AN, Moutsopoulous H, Feldman J-L, Talal N: Immune complexes in hepatitis B antigen-associated periarteritis nodosa. Detection by antibody-dependent cell-mediated cytotoxicity and the Raji cell assay. Am J Med 62:783–791, 1977
  69. Reed WD, Eddleston ALFW, Cullens H, et al: Infusion of hepatitis-B antibody in antigen-positive active chronic hepatitis. Lancet 2:1347–1351, 1973
  70. Anh-Tuan N, Novak E: Hepatitis B surface antigen circulating immune complexes [HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers. Clin Exp Immunol 43:246–253, 1981
  71. Nowoslawski A, Krawczynski K, Brzosko WJ, Madalinski K: Tissue localization of Australia antigen immune complexes in acute and chronic hepatitis and liver cirrhosis. Am J Pathol 68:31–55, 1972
  72. Nowoslawski W, Krawczynski K, Nazarewicz T, Slusarczyk J: Immunopathological aspects of hepatitis type B. Am J Med Sci 270:229–239, 1975
  73. Leung DYM, Collins T, Lapierre LA, Geha RS, Pober JS: Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 77:1428–1435, 1986 | PubMed | ISI | ChemPort |
  74. Cochrane C, Weigle WO, Dixon FJ: The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis. J Exp Med 110:481–493, 1959 | Article | PubMed | ISI | ChemPort |
  75. Cream JJ, Bryceson ADM, Ryder G: Disappearance of immunoglobulin and complement from the Arthus reaction and its relevance to studies of vasculitis in man. Brit J Derm 84:106–109, 1971
  76. Braverman IM, Yen, A: Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angiitis. J Invest Derm 64:105–112, 1975
  77. Knieser MR, Jenis EH, Lowenthal DT, Bancroft WH, Burns W, Shalhoub R: Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol 97:193–200, 1974
  78. Couser WG, Salant DJ: In situ immune complex formation and glomerular injury. Kidney Int 17:1–13, 1980 | PubMed | ISI | ChemPort |
  79. Hart MN, Tassell SK, Sadewasser KL, Schelper RL, Moore SA: Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. Am J Pathol 119:448–455, 1985
  80. Southwest Pediatric Nephrology Study Group: Hepatitis B surface antigenemia in North American children with membranous glomerulonephropathy. J Pediatr 106:571–577, 1985
  81. Kleinknecht C, Levy M, Peix A, Broyer M, Courtecuisse V: Membranous glomerulonephritis and hepatitis B surface antigen in children. J Pediatr 95:946–952, 1979 | PubMed | ISI | ChemPort |
  82. La Manna A, Polito C, Del Gado R, Olivieri AN, Di Tor R: Hepatitis B surface antigenaemia and glomerulopathies in children. Acta Paediatr Scand 74:122–125, 1985
  83. Slusarczyk J, Michalak T, Nazarewicz-De Mezer T, Krawczynski K, Nowoslawski A: Membranous glomerulopathy associated with hepatitis B core antigen immune complexes in children. Am J Pathol 98:29–39, 1980
  84. Wyszynska T, Jung H, Madalinski K, Morzycka M: Hepatitis B mediated glomerulonephritis in children. Int J Pediatr Nephrol 5:147–150, 1984
  85. Yoshikawa N, Ito H, Yamada Y, et al: Membranous glomerulonephritis associated with hepatitis B antigen in children: A comparison with idiopathic membranous glomerulonephritis. Clin Nephrol 23:28–34, 1985
  86. Takekoshi Y, Tanaka M: Hepatitis B virus-associated glomerulonephritis in children, in Recent Advances in Pediatric Nephrology edited by Murakami K, Kitagawa T, Yabuta K, Sakai T, New York, Excerpta Medica, 1987, pp. 293–298
  87. Lee HS, Choi Y, Yu SH, Koh HI, Kim MJ, Ko KW: A renal biopsy study of hepatitis B virus-associated nephropathy in Korea. Kidney Int 34:537–543, 1988
  88. Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Vallance-Owen J: The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Quart J Med 63:323–333, 1987
  89. Chow CB, Leung NK: Membranous glomerulonephritis in Hong Kong. (letter). Arch Dis Child 59:693–694, 1984
  90. Hsu H-C, Lin G-H, Chang M-H, Chen C-H: Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan. Clin Nephrol 20:121–129, 1983
  91. Seggie J, Nathoo K, Davies PG: Association of Hepatitis B (HBs) antigenaemia and membranous glomerulonephritis in Zimbabwean children. Nephron 38:115–119, 1984
  92. Wiggelinkhuizen J, Sinclair-Smith C, Stannard LM, Smuts H: Hepatitis B virus associated membranous glomerulonephritis. Arch Dis Childhood 58:488–496, 1983
  93. Rashid H, Morley AR, Ward MK, Kerr DNS, Codd AA: Hepatitis B infection glomerulonephritis. Brit Med J 283:948–949, 1981
  94. Mactier R, Boulton-Jones JM, Payton CD, Mclay A: The natural history of membranous nephropathy in the West of Scotland. Quart J Med 60:793–802, 1986
  95. Nagy J, Bajtai G, Brasch H, et al: The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. Clin Nephrol 12:109–116, 1979
  96. Sham MK, Pun KK, Yeung CK, Ng WL, Chang WK, Chan MK: Hepatitis B induced glomerulonephritis, fact or fiction? Aust NZ J Med 15:356–358, 1985
  97. Takekoshi Y, Shida N, Saheki Y, Tanaka M, Satake Y, Matsumoto S: Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet 2:1065–1068, 1978
  98. Levy M, Kleinknecht C, Droz D, Drueke T: Glomerular nephropathies and hepatitis B virus infection, in Advances in Nephrology (vol 11), edited by Bach J-F, Crosnier J, Funck-Brentano J-L, Grunfeld J-P, Maxwell MH, Chicago, Year Book Medical Publishers, Inc., 1982, pp. 341–370
  99. Zacchello G, Zancan L, Alberti A, Milanesi C, Rizzoni G, Zacchello F: [Membranous nephropathy associated with chronic hepatitis caused by hepatitis B virus]. Pediatr Med Chir 8:311–314, 1986
  100. Team of the Asian Study of Renal Disease in Children: Clinical survey of hepatitis B antigenemia associated nephropathy in children, in Pediatric Nephrology (Proceedings of the Fifth International Pediatric Nephrology Symposium, held in Philadelphia, PA, October 6–10, 1980), edited by Gruskin AB, Norman ME, The Hague/Boston/London, Martinus Nijhoff Publishers, 1981, pp. 156–164
  101. Furuse A, Hattori S, Terashima T, Karashima S, Matsuda I: Circulating immune complex in glomerulonephropathy associated with hepatitis B virus infection. Nephron 31:212–218, 1982
  102. Collins AB, Bhan AK, Dienstag JL, et al: Hepatitis B immune complex glomerulonephritis: Simultaneous glomerular deposition of hepatitis B surface and e antigens. Clin Immunol Immunopathol 26:137–153, 1983
  103. Guerra IL, Abraham AA, Kimmel PL, Sabnis SG, Antonovych TT: Nephrotic syndrome associated with chronic persistent hepatitis B in an HIV antibody positive patient. Am J Kidney Dis 10:385–388, 1987 | PubMed | ISI | ChemPort |
  104. Cogan MG, Graber ML, Connor DG: Chronic active hepatitis and membranous glomerulonephritis. Am J Gastroenterol 68:386–391, 1977
  105. Ertugrul M, Saatci U: Glomerulonephritis associated with deposition of hepatitis B surface antigen-antibody immune complexes in children. Turk J Pediatr 16:161–167, 1974
  106. Ainsworth SK, Brackett NC Jr, Hennigar GR, Givens LB: Glomerulonephritis with deposition of Australia antigen-antibody complexes in the glomerular basement membrane. (abstract) Lab Invest 30:369, 1974
  107. Cadrobbi P, Bortolotti F, Zacchello G, Rinaldi R, Armigliato M, Realdi G: Hepatitis B virus replication in acute glomerulonephritis with chronic active hepatitis. Arch Dis Child 60:583–585, 1985 | PubMed | ChemPort |
  108. Kohler PF, Cronin RE, Hammond WS, Olin D, Carr RI: Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Int Med 81:448–451, 1974
  109. Bajtai G, Ambrus M, Paal M, Nagy J, Deak GY: Hepatitis-B antigenaemia associated with progressive cirrhosis and membranous glomerulonephritis. (letter). Lancet 1:102–103, 1975
  110. Moriyama M, Fukuda Y, Ishizaki M, Sugisaki Y, Masugi Y: Membranous glomerulonephritis associated with active liver cirrhosis both involved by HBs antigen. Acta Pathol Jap 26:237–250, 1976
  111. Morzycka M, Slusarczyk J: Kidney glomerular pathology in various forms of acute and chronic hepatitis. Arch Pathol Lab Med 103:38–41, 1979
  112. Takekoshi Y, Tanaka M, Miyakawa Y, Yoshizawa H, Takahashi K, Mayumi M: Free "small" and IgG-associated "large" hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med 300:814–819, 1979
  113. Gregorek H, Jung H, Ulanowicz G, Madalinski K: Immune complexes in sera of children with HBV-mediated glomerulonephritis. Arch Immunol Ther Exp 34:73–83, 1986
  114. Garcia G, Scullard G, Smith C, et al: Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon. Hepatol 5:317–320, 1985
  115. Hirsch H, Ainsworth SK, Debeukelaer M, Brissie RM, Hennigar GR: Membranous glomerulonephritis in a child asymptomatic for hepatitis B virus. Concomitant seropositivity for HBsAg and Anti-HBs. Am J Clin Pathol 75:597–602, 1981
  116. Ooi YM, Ooi BS, Pollak VE: Relationship of levels of circulating immune complexes to histologic patterns of nephritis: A comparative study of membranous glomerulonephropathy and diffuse proliferative glomerulonephritis. J Lab Clin Med 90:891–898, 1977 | PubMed | ChemPort |
  117. Lai KN, Lai FM, Tam JS, Vallance-Owen J: Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Clin Nephrol 29:229–234, 1988 | PubMed | ISI | ChemPort |
  118. Lai KN, Lai FM, Lo STH, Lam CWK: IgA nephropathy and membranous nephropathy associated with hepatitis B surface antigenemia. Human Pathol 18:411–414, 1987
  119. Magil A, Webber D, Chan V: Glomerulonephritis associated with hepatitis B surface antigenemia. Report of a case with features of both membranous and IgA nephropathy. Nephron 42:335–339, 1986
  120. Silver MM, Rance CP, Middleton PJ, Huber J: Hepatitis B-associated membranous glomerulonephritis in a child. Am J Clin Pathol 72:1034–1039, 1979
  121. Brzosko W, Nazarewicz T, Krawczynski K, Morzycka M, Nowoslawski A: Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet 2:477–482, 1974
  122. Hirose H, Udo K, Kojima M, et al: Deposition of hepatitis B antigen in membranous glomerulonephritis: Identification by F(ab')2 fragments of monoclonal antibody. Kidney Int 26:338–341, 1984 | PubMed | ISI | ChemPort |
  123. Ito H, Hattori S, Matsuda I, et al: Hepatitis B e antigen-mediated membranous glomerulonephritis. Correlation of ultra-structural changes with HBeAg in the serum and glomeruli. Lab Invest 44:214–220, 1981 | PubMed | ISI | ChemPort |
  124. Couser WG, Abrass CK: Pathogenesis of membranous nephropathy. Ann Rev Med 39:517–530, 1988 | PubMed |
  125. Lew MA, Tovey DG, Steward MW: Localization of covalent immune complexes on the epithelial side of the glomerular basement membrane in mice. Int Archs Allergy Appl Immun 75:242–249, 1984
  126. Neurath AR, Strick N: Host specificity of a serum marker for hepatitis B: Evidence that "e" antigen has the properties of an immunoglobulin. Proc Natl Acad Sci USA 74:1702–1706, 1977
  127. Agadoa LYC, Gauthier VJ, Mannik M: Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli. J Immunol 134:880–884, 1985
  128. Friend PS, Michael AF: Hypothesis: Immunologic rationale for the therapy of membranous lupus nephropathy. Clin Immunol Immunopathol 10:35–40, 1978
  129. Ooi BS, Ooi YM, Hsu A, Hurtubise PE: Diminished synthesis of immunoglobulin by peripheral lymphocytes of patients with idiopathic membranous glomerulonephropathy. J Clin Invest 65:789–797, 1980 | PubMed |
  130. Germuth FG Jr, Senterfit LB, Dreesman GR: Immune complex disease. V. The nature of the circulating complexes associated with glomerular alterations in the chronic BSA-rabbit system. Johns Hopkins Med J 130:344–357, 1972 | PubMed |
  131. Dixon FJ, Feldman JD, Vazquez JJ: Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med 113:899–937, 1961 | Article | PubMed | ISI | ChemPort |
  132. Oldstone MBA, Dixon FJ: Immune complex disease in chronic viral infections. Exp Med 134:32s–40s, 1971
  133. Oldstone MBA, Dixon FJ: Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. J Exp Med 129:483–499, 1969 | Article | PubMed | ISI | ChemPort |
  134. Maggiore Q, Bartolomeo F, L'Abbate A, Misefari V: HBsAg glomerular deposits in glomerulonephritis: Fact or artifact? Kidney Int 19:579–586, 1981
  135. Andrews BS, Eisenberg RA, Theofilopoulous AN, et al: Spontaneous murine lupus-like syndromes. Clinical and immuno-pathological manifestations in several strains. J Exp Med 148:1198–1215, 1978 | Article | PubMed | ISI | ChemPort |
  136. Kerjaschki D, Farquhar M: The pathogenic antigen of Hey-mann nephritis is a membrane glycoprotein of the renal proximal tubular brush border. Proc Natl Acad Sci (USA) 79:5557–5561, 1982
  137. Reed WD, Eddleston ALWF, Stern RB, et al: Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet 2:690–694, 1973
  138. Wood JR, Czaja AJ, Beaver SJ, et al: Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis. Hepatol 6:976–980, 1986
  139. Zauli D, Crespi C, Bianchi FB, Craxi A, Pisi E: Autoimmunity in chronic liver disease caused by hepatitis delta virus. Clin Pathol 39:897–899, 1986
  140. Ohtani Y, Kakumu S, Fuji A, Murase K: Autoantibodies against liver cell membrane antigens detected by enzyme-linked immunosorbent assay in acute and chronic liver disease. Clin Immunol Immunopathol 43:9–22, 1987
  141. Jensen DM, Mcfarlane IG, Portmann BS, Eddleston ALWF, Williams R: Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med 299:1–7, 1978
  142. Slusarczyk J, Michalak T: Antibodies reacting with brush borders of rat kidney tubules in sera from children with chronic hepatitis and chronic glomerulonephritis. Materia Medica Polona 51:15–17, 1984
  143. Eddleston ALWF, Mondelli M: Immunopathological mechanisms of liver cell injury in chronic hepatitis B virus infection. J Hepatol 3(Suppl 2):S17–S23, 1986
  144. Rager-Zisman B: Virus-induced autoimmunity. Israel J Med Sci 24:363–365, 1988
  145. Nochy D, Callard P, Bellon B, Bariety J, Druet P: Association of over glomerulonephritis and liver disease. A study of 34 patients. Clin Nephrol 6:422–427, 1976
  146. Silva H, Hall EW, Hill KR, Shaldon S, Sherlock S: Renal involvement in active 'juvenile' cirrhosis. J Clin Pathol 18:157–163, 1965
  147. Bridi GS, Falcon PW, Brackett NC Jr, Still WJS, Sporn IN: Glomerulo-nephritis and renal tubular acidosis in a case of chronic active hepatitis with hyperimmunoglobulinemia. Am J Med 52:267–277, 1972
  148. Whittingham S, Mackay IR: Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet 1:1333–1335, 1966
  149. Taft LI, Dineen JK, Mackay IR: The localization and binding of serum proteins in the glomeruli of kidney biopsies in disseminated lupus erythematosus and glomerulonephritis. AustAnn Med 7:5–14, 1958
  150. Penner E: Nature of immune complexes in autoimmune chronic active hepatitis. Gastroenterol 92:304–308, 1987
  151. Dudley FJ, Fox RA, Sherlock S: Cellular immunity and hepatitis-associated Australia antigen liver disease. Lancet 1:723–726, 1972
  152. London WT, Drew JS, Lustbader ED, Werner BG, Blumberg BS: Host responses to hepatitis B infection in patients in a chronic hemodialysis unit. Kidney Int 12:51–58, 1977 | PubMed | ISI | ChemPort |
  153. Ikeda T, Lever AML, Thomas HC: Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life. Hepatol 6:962–965, 1986
  154. Matsumoto K, Osakabe K, Katayama H, Yoshizawa N, Harada M, Hatano M: Cell-mediated immunity in idiopathic membranous nephropathy. Int Arch Allergy Appl Immunol 66:310–315, 1981
  155. Matsumoto K, Osakabe Q, Hatanq M: Impaired cell-mediated immunity in idiopathic membranous nephropathy mediated by suppressor cells. Clin Nephrol 20:213–214, 1983
  156. Klouda PT, Acheson EJ, Goldby FS, et al: Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet 2:770–771, 1979
  157. Tomura S, Kashiwabara H, Tuchida H, et al: Stong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese. Nephron 36:242–245, 1984
  158. Gran J, Husby G, Thorsby E: HLA DR antigens and gold toxicity. Ann Rheu Dis 42:63–66, 1983
  159. Mackay IR: Genetic aspects of immunologically mediated liver disease. Semin Liver Dis 4:13–25, 1984
  160. Hirschel BJ, Benusiglio LN, Favre H, et al: Glomerulonephritis associated with hepatitis B. Report of a case and review of the literature. Clin Nephrol 8:404–409, 1977
  161. Iida H, Izumino K, Asaka M, et al: Membranoproliferative glomerulonephritis associated with chronic hepatitis B in adults: Pathogenetic role of HBsAg. Am J Nephrol 7:319–324, 1987
  162. Knecht GL, Chisari FV: Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen. Gastroenterology 75:1152–1156, 1978
  163. Amemiya S, Ito H, Kato K, Sakaguchi H, Hasegawa O, Hajikano H: A case of membranous proliferative glomerulonephritis type III (Burkholder) with the deposition of both HBeAg and HBsAg. Int J Pediatr Nephrol 4:267–273, 1983
  164. Ozawa T, Levinsohn P, Orsini E, Mcintosh RM: Acute immune complex disease associated with hepatitis. Arch Pathol Lab Med 100:484–486, 1976
  165. Stratta P, Camussi G, Ragni R, Vercellone A: Hepatitis-B antigenaemia associated with active chronic hepatitis and mesan-gioproliferative glomerulonephritis. (letter) 2:179, 1975
  166. Eknoyan G, Gyorkey F, Dichoso C, Martinez-Maldonado M, Suki WN, Gyorkey P: Renal morphological and immunological changes associated with acute viral hepatitis. Kidney Int 1:413–419, 1972 | PubMed | ChemPort |
  167. Gyorkey F, Hollinger FB, Eknoyan G, et al: Immune-complex glomerulonephritis, intranuclear particles in hepatocytes, and in vivo clearance rates in subhuman primates inoculated with HbsAg-containing plasma. Exp Mol Pathol 22:350–365, 1975
  168. Lai KN, Lai FM, Lo S, Ho CP, Chan KW: IgA nephropathy associated with hepatitis B virus antigenemia. Nephron 47:141–143, 1987 | ISI | ChemPort |
  169. Gauthier VJ, Striker GE, Mannik M: Glomerular localization of preformed immune complexes prepared with anionic antibodies or with cationic antigens. Lab Invest 50:636–644, 1984
  170. Yoffe B, Noonan CA, Melnick JL, Hollinger FB: Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J Infect Dis 153:471–477, 1986
  171. Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C: Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol 65:651–655, 1984 | PubMed |
  172. Halpern MS, England JM, Deery DT, et al: Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. Proc Natl Acad Sci USA 80:4865–4869, 1983
  173. Freiman JS, Jilbert AR, Dixon RJ, et al: Experimental duck hepatitis B viral infection: Pathology and evolution of hepatic and extrahepatic infection. Hepatol 8:507–513, 1988
  174. Czaja AJ: Serologic markers of hepatitis A and B in acute and chronic liver disease. Mayo Clin Proc 54:721–732, 1979
  175. Nakamoto Y, Iida H, Kobayashi K, et al: Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part. Virchows Arch (Pathol Anat) 392:45–54, 1981
  176. Berger J, Yaneva H, Nabarra B: Glomerular changes in patients with cirrhosis of the liver, in Advances in Nephrology, edited by Hamburger J, Crosnier J, Grunfeld J-P, Maxwell M, (vol 7), Chicago, Year Book Medical Publishers, Inc, 1978, pp. 3–14
  177. Lesavre PH, Digeon M, Bach JF: Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol 48:61–69, 1982
  178. Maggiore G, Martini A, Grifeo S, De Giacoma C, Scotta MS: Hepatitis B virus infection and Schonlein-Henoch purpura. Am J Dis Child 138:681–682, 1984
  179. Iida H, Nakamoto Y, Kobayashi K, Dohi K, Hattori N, Takeuchi T: Hepatic glomerulonephritis. Virchows Arch (Pathol Anat) 392:55–62, 1981
  180. Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC: Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 296:1501–1504, 1977 | PubMed | ChemPort |
  181. Levo Y, Gorevic PD, Kassab H, Zucker-Franklin D, Gigli I, Franklin EC: Mixed cryoglobulinemia—an immune complex disease often associated with hepatitis B virus infection. Trans Assoc Am Phys 90:167–173, 1977
  182. Bombardiere S, Paoletti P, Ferri C, Di Munno O, Fornai E, Giuntini C: Lung involvement in essential mixed cryoglobulinemia. Am J Med 66:748–756, 1979
  183. Perez GO, Pardo V, Fletcher M: Renal involvement in essential mixed cryoglobulinemia. Am J Kidney Dis 10:276–280, 1987
  184. Alarcon-Segovia D, Fishein E, Diaz-Jouanen E: Presence of hepatitis-associated antigen in systemic lupus erythematosus. Clin Exp Immunol 12:9–19, 1972
  185. Ziegenfuss JF Jr, Byrne EB, Stoloff IL, Burka EF: Australia antigen in systemic lupus erythematosus. (letter). Lancet 1:800, 1972
  186. Looi LM, Prathap K: Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus. Histopathology 6:141–147, 1982
  187. Lai KN, Lai FM, Lo S, Leung A: Is there a pathogenetic role of hepatitis B virus in lupus nephritis? Arch Pathol Lab Med 111:185–188, 1987
  188. Panush RS, Alpert E, Schur PH: Absence of Australia antigen and antibpdy in patients with rheumatic diseases. Arth Rheum 14:782, 1971
  189. Obineche EN, Awunor-Renner C: The role of hepatitis B surface antigen (HBsAg) in acute glomerulonephritis in adults. East African Med J 58:341–343, 1981
  190. Oren I, Hershow RC, Ben-Porath E, et al: A common-source outbreak of fulminant hepatitis B in a hospital. Ann Intern Med 110:691–698, 1989
  191. Thomas HC, Lever AML, Scully LJ, Pignatelli M: Approaches to the treatment of hepatitis B virus and delta-related liver disease. Semin Liver Dis 6:34–40, 1986
  192. Blumberg BS, Gerstley BJS, Hungerford DA, London WT, Sutnick AI: A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Int Med 66:924–931, 1967
  193. Bryson YJ, Winter HS, Gard SE, Fischer TJ, Stiehm ER: Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol 55:191–200, 1980 | Article | PubMed | ChemPort |
  194. Gregory PB, Knauer CM, Kempson RL, Miller R: Steroid therapy in severe viral hepatitis. A double-blind, randomized trial of methyl-prednisolone versus placebo. N Engl J Med 294:681–687, 1976
  195. Chiaramonte M, Dardanoni L, Farini R, et al: Acute hepatitis B is a more severe disease than hepatitis A. Gastroenterology 69:270–271, 1975
  196. Lam KC, Lai CL, Ng RP, Trepo C, Wu PC: Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 304:380–386, 1981
  197. Hoofnagle JH, Davis GL, Pappas SC, et al: A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Ann Int Med 104:12–17, 1986
  198. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB: Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 81:987–991, 1981
  199. Wands JR, Chura CM, Roll FJ, Maddrey WC: Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoprolif-erative disorders. Gastroenterology 68:105–112, 1975
  200. Hanson CA, Sutherland DE, Snover DC: Fulminant hepatic failure in an HBsAg carrier renal transplant patient following cessation of immunosuppressive therapy. Transplantation 39:311–312, 1985
  201. Parfrey PS, Forbes RDC, Hutchinson TA, et al: The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 39:610–615, 1985 | PubMed | ISI | ChemPort |
  202. Frohnert PP, Sheps SG: Long-term follow-up study of periarteritis nodosa. Am J Med 43:8–14, 1967
  203. Leib ES, Restivo C, Paulus HE: Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 67:941–947, 1979
  204. Oriente P, Riccio A, Farinaro C, et al: Cyclophosphamide treatment in polyarteritis nodosa. Clin Rheumatol 5:193–200, 1986
  205. Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK: Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 300:524–530, 1979
  206. Guillevin L: Treatment of polyarteritis nodosa with Dapsone. Scand J Rheumatol 15:95–96, 1986
  207. Chalopin JM, Rifle G, Turc JM, Cortet P, Severac M: Immunological findings during successful treatment of HBsAg-associated polyarteritis nodosa by plasmapheresis alone. Brit Med J 1:368, 1980
  208. Collaborative study of the adult idiopathic nephrotic syndrome. A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 301:1301–1306, 1979
  209. Ponticelli C, Zucchelli P, Imbasciati E, et al: Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 310:946–950, 1984 | PubMed | ISI | ChemPort |
  210. West ML, Jindal KK, Bear PA, Goldstein MB: A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis. Kidney Int 32:579–584, 1987 | PubMed | ISI | ChemPort |
  211. Habib R, Kleinknecht C, Gubler M-C: Extramembranous glomerulonephritis in children: Report of 50 cases. J Pediatr 82:754–766, 1973
  212. Mizushima N, Kanai K, Matsuda H, et al: Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon. Gastroenterology 92:524–526, 1987 | PubMed | ChemPort |
  213. De Man RA, Schalm SW, Van Der Heijden AJ, Ten Kate FWJ, Wolff ED, Heijtink RA: Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy. J Hepatol 8:367–372, 1989
  214. Lisker-Melman M, Webb D, Di Bisceglie AM, et al: Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon. Ann Intern Med 111:479–483, 1989 | PubMed | ChemPort |
  215. Esteban R, Buti M, Valles M, Allende H, Guardia J: Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate. (letter) Hepatol 6:762–763, 1986
  216. Garcia G, Smith CI, Weissberg JI, et al: Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. Ann Int Med 107:278–285, 1987

Extra navigation

.
ADVERTISEMENT